Summary
Nearly a dozen states have enacted provisions related to pharmaceutical price transparency and patent litigation settlements. Many of them impose requirements on drug manufacturers that biosimilars companies need to follow.
In this webinar, we will provide an overview of these new state pharmaceutical laws along with tips for navigating compliance across company activities.
Speakers
- /en/people/c/cohen-roger
Roger A. Cohen
Partner
